Forex Today: Dollar in trouble as pandemic-related concerns were set aside

Here is what you need to know on Tuesday, July 14:

Risk appetite dominated the financial world for most of this Monday, weighing on the American currency. The EUR/USD pair reached 1.1375, retreating ahead of the US close as Wall Street turned lower and closed in the red. There was no particular catalyst for equities slump, but profit-taking as the earnings season quick-starts this Tuesday.

The Pound was among the weakest, losing the 1.2600 level against the dollar way ahead of the U-turn in the market’s mood. No progress in Brexit talks and chatter about negative rates weighed on the Sterling.

The main theme is the ongoing pandemic. The number of global new coronavirus cases remains on the rise. Nevertheless, governments are trying to avoid new lockdowns, which somehow fueled the market’s positive sentiment throughout the day.

Also, the US FDA approved the Fast Track designation to the joint coronavirus vaccine efforts made by German BioNTech and US pharmaceutical Pfizer. Several vaccines seem to be making progress, another risk-on factor that got erased by equities slump at the end of the day.

China’s premier Li said that the economy is showing a steady recovery. The market took the headline with a pinch of salt. Additionally, China issued a travel advisory for Australia, with the ministry of foreign affairs citing racism, violence, and anti-Chinese sentiment.

The earnings season is starting this Tuesday with major banks Citigroup, JP Morgan, and Wells Fargo reports.

Commodities feel the heat at the end of the day but held within familiar levels. Gold settled at $1,804 a troy ounce, while WTI finished the day around $39.60 a barrel.

Cryptocurrency Market News: Vodafone and others are using Blockchain, Bitcoin is trying to hold $9,200

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.